Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1,011 INR | -0.69% | -1.14% | +24.63% |
09/04 | Natco Pharma Gets US FDA Warning Letter after Inspection of Kothur, India Unit | MT |
27/03 | NATCO Pharma Limited Announces Board Appointments | CI |
Business Summary
Number of employees: 3,946
Sales per Business
INR in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Pharmaceuticals
98.5
%
| 19,399 | 99.7 % | 26,662 | 98.5 % | +37.44% |
Agro Chemicals
1.5
%
| 49 | 0.3 % | 409 | 1.5 % | +734.69% |
Sales per region
INR in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
59.3
%
| 9,782 | 50.3 % | 16,060 | 59.3 % | +64.18% |
Rest of the World
22.2
%
| 3,576 | 18.4 % | 5,997 | 22.2 % | +67.70% |
India
18.5
%
| 6,090 | 31.3 % | 5,014 | 18.5 % | -17.67% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 46 | 03/00/03 | |
Founder | 78 | 19/81/19 | |
Director of Finance/CFO | - | - | |
Chief Operating Officer | - | - | |
Compliance Officer | - | 01/22/01 | |
M. Pulla Reddy
CTO | Chief Tech/Sci/R&D Officer | 66 | 01/94/01 |
Chief Tech/Sci/R&D Officer | 71 | 11/93/11 | |
Director/Board Member | - | - | |
Director/Board Member | 66 | 12/14/12 | |
Sadasiva N. Rao
LAW | General Counsel | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Founder | 78 | 19/81/19 | |
Chief Executive Officer | 46 | 03/00/03 | |
Director/Board Member | 70 | 18/14/18 | |
Leela Digumarti
BRD | Director/Board Member | - | 22/14/22 |
M. U. R Naidu
BRD | Director/Board Member | 74 | 11/15/11 |
Chief Tech/Sci/R&D Officer | 71 | 11/93/11 | |
Director/Board Member | 66 | 12/14/12 | |
Director/Board Member | - | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 179,109,870 | 83,757,134 ( 46.76 %) | 0 | 46.76 % |
Company contact information
NATCO Pharma Ltd.
NATCO House Road No. 2
500034, Hyderabad
+91 40 2354 7532
http://www.natcopharma.co.inGroup companies
Name | Category and Sector |
---|---|
Natco Pharma (Canada), Inc.
|
Sector
Sales per Business
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+24.63% | 2.18B | |
+33.25% | 699B | |
+25.33% | 571B | |
-3.55% | 364B | |
+18.16% | 326B | |
+4.36% | 286B | |
+14.83% | 236B | |
+4.91% | 198B | |
-10.10% | 194B | |
-3.69% | 149B |
- Stock Market
- Equities
- NATCOPHARM Stock
- Company NATCO Pharma Limited